Blood Safety (Industry News)

Company Acquires Rights to Blood Filtration Technique to Remove Viruses

Published in Blood Weekly, January 27th, 2000

Aethlon Medical Inc., (formally known as Bishop Equities Inc.) announced that it has acquired the rights to a new medical device technology designed to remove various viruses from the blood.

Aethlon Medical is a developer of medical devices that treat a wide range of medical conditions through extracorporeal therapies, with operations in La Jolla, California, and Buffalo, New York.

The acquired technology applies a blood filtration technique developed by Hemex Inc., a wholly-owned subsidiary of Aethlon Medical, in a novel combination of surface modification technology and synthetic DNA hybridization technology. By embedding both antibodies and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2000-01-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry